Antheia Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
65
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$80M
- Investors
-
23
Antheia General Information
Description
Operator of a biotechnology company intended to develop plant-inspired medicines. The company's cost-competitive, plant-based medicines are made using synthetic biology, informatics, and fermentation technology to harness beneficial molecules from plants to create active pharmaceutical ingredients, enabling healthcare organizations to provide patients with natural and healthier medication.
Contact Information
Website
www.antheia.bioCorporate Office
- 1430 O'Brien Drive
- Suite A
- Menlo Park, CA 94025
- United States
Corporate Office
- 1430 O'Brien Drive
- Suite A
- Menlo Park, CA 94025
- United States
Antheia Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Later Stage VC (Series C) | 27-Jan-2026 | $80M | Completed | Generating Revenue | ||
| 11. Later Stage VC (Series B) | 30-Jun-2021 | Completed | Product Development | |||
| 10. Debt - PPP | 13-Apr-2020 | Completed | Product Development | |||
| 9. Debt - General | 31-Dec-2019 | Completed | Product Development | |||
| 8. Debt - General | 01-Dec-2018 | Completed | Product Development | |||
| 7. Later Stage VC (Series B) | 04-Sep-2018 | Completed | Product Development | |||
| 6. Grant | 01-Jan-2018 | Completed | Startup | |||
| 5. Early Stage VC (Series A) | 26-May-2017 | Completed | Startup | |||
| 4. Grant | 01-Jan-2017 | $900K | $1.97M | Completed | Startup | |
| 3. Grant | 01-Jan-2016 | $450K | $1.97M | Completed | Startup |
Antheia Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C-1 | ||||||||
| Series C-2 | ||||||||
| Series B-3 | ||||||||
| Series B-2 | ||||||||
| Series B-1 | ||||||||
| Series A | 2,791,257 | $0.000100 | $0.71 | $8.6 | $8.6 | 1x | $8.6 | 1.39% |
| Seed | 2,237,533 | $0.000100 | $0.09 | $1.12 | $1.12 | 1x | $1.12 | 1.11% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Antheia Comparisons
Industry
Financing
Details
Antheia Competitors (3)
One of Antheia’s 3 competitors is Conagen, a Corporate Backed or Acquired company based in Bedford, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Conagen | Corporate Backed or Acquired | Bedford, MA | ||||
| Mammoth Biosciences | Venture Capital-Backed | Brisbane, CA | ||||
| Biosyntia | Venture Capital-Backed | Copenhagen, Denmark |
Antheia Patents
Antheia Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4594342-A2 | Methods of improving production of morphinan alkaloids and derivatives | Pending | 29-Sep-2022 | ||
| US-20260103736-A1 | Methods of improving production of morphinan alkaloids and derivatives | Pending | 29-Sep-2022 | ||
| WO-2024073755-A2 | Methods of improving production of morphinan alkaloids and derivatives | Inactive | 29-Sep-2022 | ||
| WO-2024073755-A3 | Methods of improving production of morphinan alkaloids and derivatives | Inactive | 29-Sep-2022 | ||
| US-12409144-B2 | Oxygen capsule as well as preparation method and application thereof | Active | 19-Oct-2021 | A61K9/4833 |
Antheia Signals
Antheia Investors (23)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| America's Frontier Fund | Venture Capital | Minority | ||
| Athos (Family Office) | Family Office | Minority | ||
| Civilization Ventures | Venture Capital | Minority | ||
| Echo Investment Capital | PE/Buyout | Minority | ||
| EDBI | Venture Capital | Minority |
Antheia FAQs
-
When was Antheia founded?
Antheia was founded in 2013.
-
Where is Antheia headquartered?
Antheia is headquartered in Menlo Park, CA.
-
What is the size of Antheia?
Antheia has 65 total employees.
-
What industry is Antheia in?
Antheia’s primary industry is Biotechnology.
-
Is Antheia a private or public company?
Antheia is a Private company.
-
What is the current valuation of Antheia?
The current valuation of Antheia is .
-
What is Antheia’s current revenue?
The current revenue for Antheia is .
-
How much funding has Antheia raised over time?
Antheia has raised $176M.
-
Who are Antheia’s investors?
America's Frontier Fund, Athos (Family Office), Civilization Ventures, Echo Investment Capital, and EDBI are 5 of 23 investors who have invested in Antheia.
-
Who are Antheia’s competitors?
Conagen, Mammoth Biosciences, and Biosyntia are competitors of Antheia.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process